Subscribe To Our Free Newsletter |
Dr Reddy’s finishes IP rights purchase for Fondaparinux sodium
The pharma company has announced that it has completed the purchase of worldwide exclusive intellectual property rights for Fondaparinux sodium, its generic anti-coagulant drug from its Australian partner, Alchemia Limited. Earlier, the company had signed a term sheet for this transaction in September, 2015.